Gland Pharma Q1 FY27 is out — net profit ₹364 cr, up 69% YoY, even as revenue slipped 15% to ₹1,287 cr.
Profit rising while sales fall is a margin/one-off story worth a closer look.
→ Details: https://marketchacha.com/companies/GLAND
This article is for educational and informational purposes only. It is not financial advice, investment recommendation, or a solicitation to buy or sell securities. Investing involves significant risks. I am not a SEBI-registered investment advisor. Readers should consult their own financial advisor and conduct their own research before making any investment decisions.
Comments
Join the conversation
Sign in to join the conversation.
Follow replies, add your view, and take part in the discussion.
Sign in to commentLoading comments...